Literature DB >> 27612469

[Radical cystectomy vs. chemoradiation for the treatment of T2-4a N0 M0 bladder cancer].

Gunther Klautke1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27612469     DOI: 10.1007/s00066-016-1043-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

Authors:  Raymond H Mak; Daniel Hunt; William U Shipley; Jason A Efstathiou; William J Tester; Michael P Hagan; Donald S Kaufman; Niall M Heney; Anthony L Zietman
Journal:  J Clin Oncol       Date:  2014-11-03       Impact factor: 44.544

2.  15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.

Authors:  Frens Steffen Krause; Bernhard Walter; Oliver Josef Ott; Lothar Häberle; Christian Weiss; Claus Rödel; Bernd Wullich; Rolf Sauer
Journal:  Anticancer Res       Date:  2011-03       Impact factor: 2.480

3.  Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  J Bellmunt; A Orsola; J J Leow; T Wiegel; M De Santis; A Horwich
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976

4.  Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial.

Authors:  Timur Mitin; Daniel Hunt; William U Shipley; Donald S Kaufman; Robert Uzzo; Chin-Lee Wu; Mark K Buyyounouski; Howard Sandler; Anthony L Zietman
Journal:  Lancet Oncol       Date:  2013-07-01       Impact factor: 41.316

5.  Radical cystectomy vs. chemoradiation in T2-4aN0M0 bladder cancer: a case-control study.

Authors:  Ofer N Gofrit; Rony Nof; Amichai Meirovitz; Dov Pode; Stephen Frank; Ran Katz; Amos Shapiro; Ezekiel H Landau; Guy Hidas; Vladimir Yutkin; Mordechai Duvdevani; Mark Wygoda
Journal:  Urol Oncol       Date:  2014-11-04       Impact factor: 3.498

6.  Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia.

Authors:  Michael Wittlinger; Claus M Rödel; Christian Weiss; Steffen F Krause; Reinhard Kühn; Rainer Fietkau; Rolf Sauer; Oliver J Ott
Journal:  Radiother Oncol       Date:  2009-11       Impact factor: 6.280

7.  Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer.

Authors:  Christian Weiss; Dirk G Engehausen; Frens S Krause; Thomas Papadopoulos; Jürgen Dunst; Rolf Sauer; Claus Rödel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-30       Impact factor: 7.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.